Suzuken Co., Ltd.

Tokyo Stock Exchange 9987.T

Suzuken Co., Ltd. Gross Profit for the year ending March 31, 2024: USD 1.22 B

Suzuken Co., Ltd. Gross Profit is USD 1.22 B for the year ending March 31, 2024, a -9.51% change year over year. Gross profit is the difference between revenue and the cost of revenue, representing the profit earned from core business operations.
  • Suzuken Co., Ltd. Gross Profit for the year ending March 31, 2023 was USD 1.35 B, a 2.27% change year over year.
  • Suzuken Co., Ltd. Gross Profit for the year ending March 31, 2022 was USD 1.32 B, a -7.21% change year over year.
  • Suzuken Co., Ltd. Gross Profit for the year ending March 31, 2021 was USD 1.43 B, a -21.04% change year over year.
  • Suzuken Co., Ltd. Gross Profit for the year ending March 31, 2020 was USD 1.81 B, a 5.73% change year over year.
Key data
Date Gross Profit Operating Income EBIT EBITDA
Market news
Loading...
Tokyo Stock Exchange: 9987.T

Suzuken Co., Ltd.

CEO Mr. Shigeru Asano
IPO Date Jan. 1, 2001
Location Japan
Headquarters 8 Higashi Kataha-machi
Employees 13,086
Sector Health Care
Industries
Description

Suzuken Co., Ltd., together with its subsidiaries, primarily engages in the wholesale of pharmaceuticals in Japan and internationally. The company operates in four segments: Pharmaceutical Distribution Business, Pharmaceutical Manufacturing Business, Pharmacy Business, and Healthcare-Related Services Business. The Pharmaceutical Distribution Business segment procures ethical drugs, diagnostic reagents, medical equipment and supplies, and other health-related items from manufacturers and supplies to medical institutions and pharmacies. The Pharmaceutical Manufacturing Business segment engages in the research and development, manufacturing, and marketing of ethical pharmaceuticals and diagnostic products focusing on the areas of diabetes and kidney diseases. The Pharmacy Business segment provides services through family pharmacists, as well as improves the operations of local pharmacies and provides educational support. The Healthcare-Related Services Business segment provides manufacturer support services, such as contract distribution for manufacturers; distribution of orphan drugs; and nursing care services, as well as develops, manufactures, and sells electrocardiographs, sphygmomanometers, stethoscopes, medical materials, and health promotion equipment. Suzuken Co., Ltd. also publishes medical magazines for medical institutions. The company has collaboration with Bushu Pharmaceuticals Ltd. provide contract specialty drug services. Suzuken Co., Ltd. was founded in 1932 and is headquartered in Nagoya, Japan.

Similar companies

7459.T

MediPal Holdings Corporation

USD 14.64

-0.31%

4507.T

Shionogi & Co., Ltd.

USD 14.22

-0.40%

2784.T

Alfresa Holdings Corporation

USD 13.29

-0.18%

2768.T

Sojitz Corporation

USD 19.71

-0.98%

9989.T

Sundrug Co.,Ltd.

USD 25.64

-1.47%

StockViz Staff

January 15, 2025

Any question? Send us an email